124 related articles for article (PubMed ID: 28403497)
1. [Not Available].
Albers P
Aktuelle Urol; 2017 Feb; 48(1):79-87. PubMed ID: 28403497
[No Abstract] [Full Text] [Related]
2. [Retroperitoneal residual tumor resection after chemotherapy of malignant testicular cancers].
Albers P
Aktuelle Urol; 2012 May; 43(3):197-206. PubMed ID: 22639031
[No Abstract] [Full Text] [Related]
3. Postchemotherapy residual masses in advanced seminoma: current management and outcomes.
Quek ML; Simma-Chiang V; Stein JP; Pinski J; Quinn DI; Skinner DG
Expert Rev Anticancer Ther; 2005 Oct; 5(5):869-74. PubMed ID: 16221056
[TBL] [Abstract][Full Text] [Related]
4. Late Relapse of Nonseminomatous Germ Cell Tumor 24 Years Later.
Riedinger CB; Labbate C; Werntz RP; Eggener SE
Urology; 2018 Dec; 122():16-18. PubMed ID: 30170087
[No Abstract] [Full Text] [Related]
5. Retroperitoneal mass and burned out testicular tumor.
Jaber S
Saudi J Kidney Dis Transpl; 2010 May; 21(3):542-3. PubMed ID: 20427889
[No Abstract] [Full Text] [Related]
6. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
Winter C; Pfister D; Busch J; Bingöl C; Ranft U; Schrader M; Dieckmann KP; Heidenreich A; Albers P
Eur Urol; 2012 Feb; 61(2):403-9. PubMed ID: 22078334
[TBL] [Abstract][Full Text] [Related]
7. The significance of resections for residual masses after chemotherapy in metastatic testicular tumors.
Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Saito S; Ohyama C; Sato M; Kawamura S; Numahata K; Ito A; Tokuyama S
Int J Urol; 1999 Jun; 6(6):305-13. PubMed ID: 10404307
[TBL] [Abstract][Full Text] [Related]
8. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
Jacqmin D
Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
[No Abstract] [Full Text] [Related]
9. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
Culine S
Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
[No Abstract] [Full Text] [Related]
10. [Surgery of residual masses after chemotherapy in patients with testicular cancer].
Fléchon A; Rivoire M; Berger N
Rev Prat; 2007 Feb; 57(4):389-98. PubMed ID: 17455741
[TBL] [Abstract][Full Text] [Related]
11. [Retroperitoneal seminoma. A case report and literature review].
Troisfontaines E; Linder JL
Acta Urol Belg; 1996 Mar; 64(1):55-9. PubMed ID: 8659336
[TBL] [Abstract][Full Text] [Related]
12. Management of post-chemotherapy residual masses in advanced seminoma.
Flechon A; Bompas E; Biron P; Droz JP
J Urol; 2002 Nov; 168(5):1975-9. PubMed ID: 12394688
[TBL] [Abstract][Full Text] [Related]
13. Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio J; Germà JR
J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
[No Abstract] [Full Text] [Related]
14. Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.
Bilen MA; Hariri H; Leon C; Guo CC; Kuban DA; Pisters LL; Tu SM
Clin Genitourin Cancer; 2014 Aug; 12(4):e147-50. PubMed ID: 24674785
[No Abstract] [Full Text] [Related]
15. Extensive surgery in metastatic testicular cancer.
Melchior D; Müller SC; Albers P
Aktuelle Urol; 2003 Jul; 34(4):214-22. PubMed ID: 14566667
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography scans in postchemotherapy seminoma patients with residual masses: a retrospective review from Indiana University Hospital.
Lewis DA; Tann M; Kesler K; McCool A; Foster RS; Einhorn LH
J Clin Oncol; 2006 Dec; 24(34):e54-5. PubMed ID: 17135635
[No Abstract] [Full Text] [Related]
17. Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything.
Culine S; Droz JP
J Clin Oncol; 1996 Oct; 14(10):2884-5. PubMed ID: 8874350
[No Abstract] [Full Text] [Related]
18. [Late relapse of stage I testicular seminoma after 11 years: successful treatment with chemotherapy alone].
Detti B; Cipressi S; Di Cataldo V; Biti G
Actas Urol Esp; 2010 Jan; 34(1):118-9. PubMed ID: 20223144
[No Abstract] [Full Text] [Related]
19. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of testicular seminoma.
Huddart RA; Kataja VV;
Ann Oncol; 2005; 16 Suppl 1():i40-2. PubMed ID: 15888748
[No Abstract] [Full Text] [Related]
20. Extragonadal germ cell tumour with the "burned out" phenomenon mimicking a retroperitioneal tumour of neurogenic origin.
González R; Montoto Santomé P; Iglesias Porto E; Pérez Moreiras MI; Salem Ali M; Mateo Cambón LA; Bal Nieves F; Arija Val JF
Arch Esp Urol; 2012 Dec; 65(10):900-2. PubMed ID: 23269339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
